content

Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer

Albumedix Ltd., the world leader in recombinant human albumin (rAlb), announced the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as...

Sygnature expands capabilities with acquisition of Alderley Oncology

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquisition of...

Messe Frankfurt to focus on highlighting strong anti-counterfeiting measures in wake of Covid-19

As demand for medical supplies soars worldwide in the fight against Covid-19, there is a parallel risk of substandard and counterfeit medicines in the...

Serialization: Syntegon joins OPEN-SCS Group

Syntegon Technology recently joined the Open Serialization Communication Standard (OPEN-SCS) Group. Joint goals include the fight against pharmaceutical counterfeiting and the establishment of interoperable...

CPhI Worldwide 2020 Implements new ‘Informa AllSecure Standard’

CPhI Worldwide โ€“ organised by Informa Markets โ€“ will this year be organised in accordance with Informaโ€™s AllSecure health and safety standard in response...

Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Greenphire, the global leader in financial lifecycle management for clinical trials, announced the launch of EnvisiX to address the budgeting challenges experienced by global...

WuXi AppTec Appoints Dr. David Chang as CEO of WuXi Advanced Therapies Business Unit

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announced the appointment of Dr. David Chang as Chief...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read